Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA approves Mylan and Biocon’s Fulphila
Fulphila has been approved to reduce the duration of febrile neutropenia in patients treated with chemotherapy in certain types of…
Lupin gets US FDA nod to market fungal infection cream
The drug is indicated for the treatment of cutaneous candidiasis
FDA chief outlines new ways to speed cancer drug approvals
The new approach is part of an effort to remove regulatory barriers that drag out reviews of promising new cancer treatments
TMH team presents Biocon’s cancer study results at ASCO Annual Meeting 2018
The results of the study conducted across 536 patients in six years clearly show that Nimotuzumab will benefit a large number of…
Lupin launches generic drug in the US
The drug is indicated for prevention and control of postpartum haemorrhage
Alembic Pharma plans Rs 720-crore CAPEX for FY19
Despite the pricing pressure and buyer consolidation, the company is betting big on the US market
Serum Institute of India in MoU with Intravacc to develop bioneedles
Both will jointly develop bioneedles for vaccines against measles and rubella
A pan-India scale-up will commence during the second half of the year
Tarnea, is a technology company based in Bengaluru recently launched a cloud-based digital platform for pharma retail - the Tarnea…